NonprofitsInternational Bladder Cancer Group

Medical Research

International Bladder Cancer Group

FLEMINGTON, NJ

Total revenue

$392K

Total expenses

$311K

Net assets

$82K

Grants received

EIN

932407167

Tax year

2024

Mission

The International Bladder Cancer Group (IBCG) is a globally recognized entity that has published numerous peer-reviewed articles addressing knowledge gaps in - and providing recommendations for - the management of bladder cancer.The IBCG was formed with a primary objective being to address global educational needs and learning gaps in order to improve the care and management of patients with urothelial carcinoma. The inaugural meeting, in 2006, consisted of members selected as representatives of their varied geographic regions across Europe, North America and Asia. The members were specifically selected not only for their expertise but also to ensure representation from across the globe.Over the years, the mission of the IBCG has been to improve outcomes of patients suffering from bladder cancer through critical evaluation and leveraging of existing data to drive evidence-based treatment. An additional goal is to develop practical educational tools that are applicable to the global uro

Financials

FY 2024

Revenue

Contributions & grants$392K
Program service revenue
Investment income$48
Other revenue
Total revenue$392K

Expenses

Grants paid
Salaries & benefits
Fundraising
Other expenses$311K
Total expenses$311K
Total assets$97K
Net assets$82K

People

3 listed

NameRoleCompensation

Ashish Kamat MD

President

Board

3.5 hrs/wk

Roger Buckley MD

Vice President

Board

1 hrs/wk

Prem Kumar Parameswaran

Treasurer

Board

6.5 hrs/wk

Details

EIN932407167
NTEE codeH03
Subsection03
Ruling date2024-04
Formed2023
Employees0
INTERNATIONAL BLADDER CANCER GROUP — Mission, Financials & Grants Received | Grantivo